Add to Favorites Newsroom RSS Share
Kansas City, KS USA

Our News on Newswise


Khabele Elected as ASCI Member

Dineo Khabele, MD, director of The University of Kansas Cancer Center’s gynecologic oncology division, has been elected a new member to the American Society for Clinical Investigation (ASCI) for 2019.
8-Jan-2019 4:05 PM EST Add to Favorites


Soper Inducted into AIMBE College of Fellows

Steven Soper, PhD, member of The University of Kansas Cancer Center, was elected to the American Institute for Medical and Biomedical Engineering (AIMBE) College of Fellows.
30-Dec-2018 1:05 PM EST Add to Favorites


Workshop Promotes Patient Advocacy in Cancer Research

The University of Kansas Cancer Center and the the Midwest Cancer Alliance co-hosted an introductory training workshop for individuals who want to learn more about KU Cancer Center’s patient research advocacy program, PIVOT
10-Dec-2018 1:05 PM EST Add to Favorites

With Sozo, lymphedema screening easier, faster

Staff at The University of Kansas Cancer Center are using a new device that makes it remarkably easy and convenient to screen for lymphedema.
26-Nov-2018 11:05 AM EST Add to Favorites


A Tailored Approach to Minority Tobacco Cessation Programs

Researchers work with African American and American Indian communities to identify effective tobacco cessation strategies
24-Sep-2018 2:05 PM EDT Add to Favorites


Moving Homegrown Ideas into the Clinic

Physician-scientists at The University of Kansas Cancer center are designing and initiating their own clinical trials.
20-Sep-2018 11:05 AM EDT Add to Favorites


Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer

Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the treatment protocol for an invasive type of breast cancer that accounts for one-fifth of all breast cancer patients.
29-Jun-2018 11:05 AM EDT Add to Favorites


Researchers Evaluate Methods for Quitting Tobacco

Researchers at The University of Kansas Cancer Center have received a five-year National Institutes of Health R0-1 grant to compare and evaluate the efficacy of optimized versus non-optimized tobacco cessation approaches for African American smokers.
26-Jun-2018 4:35 PM EDT Add to Favorites

see all news

Our Experts on Newswise


Triple-negative breast cancer expert Dr. Priyanka Sharma discusses latest research and clinical trial efforts.
18-Jul-2018 1:35 PM EDT


Getting Survivorship Care Planning Off the Page and Into Practice

Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT


Rewriting the Book on Chemo-Resistant Cancers with a DNA Library

KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT

see all experts

Our YouTube Videos


The University of Kansas Cancer Center is a world-class, community-based, NCI-designated cancer research and care partnership spanning two states and involving collaboration among researchers, physicians and cancer support professionals. Together, we are working toward a world without cancer. The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program. Our partnership includes cancer research and health care professionals associated with the University of Kansas Medical Center and The University of Kansas Hospital in Kansas City, The University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, The Stowers Institute for Medical Research and the members of the Midwest Cancer Alliance. Our research programs include Cancer Biology, Cancer Prevention, Cancer Control and Population Health, and Drug Discovery, Delivery and Experimental Therapeutics. Shared resources include Biospecimen, Biostatistics and Informatics, Clinical Research Office and Lead Development and Optimization.

Disease-specific working groups, including both clinicians and basic research investigators, promote collaborative opportunities and the exchange of research ideas. The disease working groups define clinical research priorities respective to their disease specialty with an emphasis on Investigator Initiated Trials (IITs). The cancer center’s current disease working groups include lung, hematology/bone marrow transplant, gastrointestinal, genitor-urinary, head and neck, breast and brain.

Breaking new ground in cancer research requires state-of-the-art facilities. A 82,400-square-foot University of Kansas Clinical Research Center, which opened in January 2012, houses the Phase I clinical trials program. A recently remodeled, 170,000-square-foot Wahl/Hixon research complex, known as The Kansas Masonic Cancer Research Institute, will house 37 cancer-focused researchers. Building a world-class cancer center that is at the forefront of discovery, development and implementation is just the beginning. The legacy of The University of Kansas Cancer Center endures when discoveries made here benefit cancer patients everywhere.


Kay Hawes
Assoc. Dir of News & Media Relations
Health Care


Pauline Horton
Communications Specialist


Natalie Lutz
Executive Director, Marketing & University Relatio


Donna Peck
Assistant Communications Director


Christine Wilson
Director of Public Relations



Chat now!